NO169067C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter

Info

Publication number
NO169067C
NO169067C NO853066A NO853066A NO169067C NO 169067 C NO169067 C NO 169067C NO 853066 A NO853066 A NO 853066A NO 853066 A NO853066 A NO 853066A NO 169067 C NO169067 C NO 169067C
Authority
NO
Norway
Prior art keywords
indoles
aminoalkyl
intermediates
carbonyl
preparation
Prior art date
Application number
NO853066A
Other languages
English (en)
Norwegian (no)
Other versions
NO853066L (no
NO169067B (no
Inventor
Malcolm Rice Bell
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO853066L publication Critical patent/NO853066L/no
Priority to NO903306A priority Critical patent/NO903306D0/no
Priority to NO903305A priority patent/NO903305D0/no
Priority to NO903304A priority patent/NO903304D0/no
Publication of NO169067B publication Critical patent/NO169067B/no
Publication of NO169067C publication Critical patent/NO169067C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
NO853066A 1984-08-06 1985-08-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter NO169067C (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO903306A NO903306D0 (no) 1984-08-06 1990-07-25 Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903305A NO903305D0 (no) 1984-08-06 1990-07-25 Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903304A NO903304D0 (no) 1984-08-06 1990-07-25 Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63793184A 1984-08-06 1984-08-06

Publications (3)

Publication Number Publication Date
NO853066L NO853066L (no) 1986-02-07
NO169067B NO169067B (no) 1992-01-27
NO169067C true NO169067C (no) 1992-05-06

Family

ID=24557949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853066A NO169067C (no) 1984-08-06 1985-08-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter

Country Status (20)

Country Link
EP (1) EP0171037B1 (fr)
JP (1) JPH0670010B2 (fr)
KR (1) KR870000548B1 (fr)
AR (1) AR244665A1 (fr)
AT (1) ATE77371T1 (fr)
AU (1) AU574817B2 (fr)
DE (1) DE3586224T2 (fr)
DK (1) DK170279B1 (fr)
ES (5) ES8609246A1 (fr)
FI (1) FI852973L (fr)
GR (1) GR851937B (fr)
IE (1) IE57863B1 (fr)
IL (1) IL75966A (fr)
MX (4) MX160612A (fr)
MY (1) MY101186A (fr)
NO (1) NO169067C (fr)
NZ (3) NZ212953A (fr)
PH (2) PH23498A (fr)
PT (1) PT80919B (fr)
ZA (1) ZA855923B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
US4840950A (en) * 1987-02-11 1989-06-20 Sterling Drug Inc. 4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
US5312829A (en) * 1990-05-21 1994-05-17 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
TW270114B (fr) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
EP1207153A1 (fr) 1999-08-26 2002-05-22 Fujisawa Pharmaceutical Co., Ltd. Procede de preparation de derives de l'indole ou de leurs sels
JP6493786B2 (ja) * 2015-01-06 2019-04-03 パナソニックＩｐマネジメント株式会社 免疫原、それを用いた抗体の製造方法、及び、そのモノクローナル抗体
JP6435505B2 (ja) * 2015-01-13 2018-12-12 パナソニックＩｐマネジメント株式会社 化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3217011A (en) * 1965-05-07 1965-11-09 Sterling Drug Inc 1-(indolyglyoxalyl)-piperidines
US3494920A (en) * 1967-12-18 1970-02-10 American Home Prod 1-di(lower)alkylamino(lower)alkyl-3-(2-substituted ethyl) indoles
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
FR2354766A1 (fr) * 1976-06-17 1978-01-13 Labaz Derives n-aminoalkyles d'indole et procedes pour les preparer
ES8605232A1 (es) * 1984-02-07 1986-03-16 Pfizer Un procedimiento para la preparacion de compuestos de 2-o- xindol

Also Published As

Publication number Publication date
MX14431A (es) 1993-08-01
ES8609246A1 (es) 1986-07-16
ES552912A0 (es) 1987-10-16
PH25360A (en) 1991-05-13
ZA855923B (en) 1986-03-26
DE3586224T2 (de) 1993-01-28
IL75966A (en) 1989-08-15
DK354485D0 (da) 1985-08-05
JPS6147463A (ja) 1986-03-07
ES8800902A1 (es) 1987-12-01
DK170279B1 (da) 1995-07-24
NZ225466A (en) 1990-02-26
ES545894A0 (es) 1986-07-16
NZ212953A (en) 1990-02-26
FI852973L (fi) 1986-02-07
MX160612A (es) 1990-03-28
ES552910A0 (es) 1987-12-16
AU4576485A (en) 1986-02-13
FI852973A0 (fi) 1985-08-01
DE3586224D1 (de) 1992-07-23
EP0171037B1 (fr) 1992-06-17
AR244665A1 (es) 1993-11-30
PT80919B (pt) 1987-09-30
ES8801203A1 (es) 1987-12-16
ES552909A0 (es) 1987-12-01
ES8800149A1 (es) 1987-10-16
EP0171037A2 (fr) 1986-02-12
NO853066L (no) 1986-02-07
PH23498A (en) 1989-08-16
ES8800901A1 (es) 1987-12-01
KR870000548B1 (ko) 1987-03-18
NZ225467A (en) 1990-02-26
ATE77371T1 (de) 1992-07-15
JPH0670010B2 (ja) 1994-09-07
IE57863B1 (en) 1993-05-05
AU574817B2 (en) 1988-07-14
KR860001805A (ko) 1986-03-22
GR851937B (fr) 1985-12-05
NO169067B (no) 1992-01-27
PT80919A (en) 1985-09-01
ES552911A0 (es) 1987-12-01
IE851930L (en) 1986-02-06
MX14432A (es) 1993-08-01
MX14429A (es) 1993-09-01
MY101186A (en) 1991-07-31
EP0171037A3 (en) 1987-08-26
IL75966A0 (en) 1985-12-31
DK354485A (da) 1986-02-07

Similar Documents

Publication Publication Date Title
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO161370C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
NO853293L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO870075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO852885L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater.
NO165023C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater.
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
NO157146C (no) Analogifremgangsmaate ved fremstilling av terapeutisk, aktive derivater av morfolinyl-daunorbicin og morfolinyl-doksorubicin.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO162721C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO863671D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO165592C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiofener og benzofuraner.
NO864130L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO864131D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO169067C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter
NO862534D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees